View in EDS

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Saved in:
Bibliographic Details
Title: The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
Authors: Steinberg MH; Department of Medicine, Boston University School of Medicine, Boston Medical Center, Massachusetts, USA. mhsteinb@bu.edu , McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, Ataga K, Swerdlow P, Kutlar A, DeCastro L, Waclawiw MA
Corporate Authors: Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up
Source: American journal of hematology [Am J Hematol] 2010 Jun; Vol. 85 (6), pp. 403-8.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 20513116
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Steinberg+MH%22">Steinberg MH</searchLink>; Department of Medicine, Boston University School of Medicine, Boston Medical Center, Massachusetts, USA. mhsteinb@bu.edu <mhsteinb@bu.edu><br /><searchLink fieldCode="AU" term="%22McCarthy+WF%22">McCarthy WF</searchLink><br /><searchLink fieldCode="AU" term="%22Castro+O%22">Castro O</searchLink><br /><searchLink fieldCode="AU" term="%22Ballas+SK%22">Ballas SK</searchLink><br /><searchLink fieldCode="AU" term="%22Armstrong+FD%22">Armstrong FD</searchLink><br /><searchLink fieldCode="AU" term="%22Smith+W%22">Smith W</searchLink><br /><searchLink fieldCode="AU" term="%22Ataga+K%22">Ataga K</searchLink><br /><searchLink fieldCode="AU" term="%22Swerdlow+P%22">Swerdlow P</searchLink><br /><searchLink fieldCode="AU" term="%22Kutlar+A%22">Kutlar A</searchLink><br /><searchLink fieldCode="AU" term="%22DeCastro+L%22">DeCastro L</searchLink><br /><searchLink fieldCode="AU" term="%22Waclawiw+MA%22">Waclawiw MA</searchLink>
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Investigators+of+the+Multicenter+Study+of+Hydroxyurea+in+Sickle+Cell+Anemia+and+MSH+Patients'+Follow-Up%22">Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227610369%22">American journal of hematology</searchLink> [Am J Hematol] 2010 Jun; Vol. 85 (6), pp. 403-8.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7610369 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203618609%22">03618609 </searchLink><i>NLM ISO Abbreviation: </i>Am J Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20513116
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ajh.21699
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 403
    Titles:
      – TitleFull: The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Steinberg MH
      – PersonEntity:
          Name:
            NameFull: McCarthy WF
      – PersonEntity:
          Name:
            NameFull: Castro O
      – PersonEntity:
          Name:
            NameFull: Ballas SK
      – PersonEntity:
          Name:
            NameFull: Armstrong FD
      – PersonEntity:
          Name:
            NameFull: Smith W
      – PersonEntity:
          Name:
            NameFull: Ataga K
      – PersonEntity:
          Name:
            NameFull: Swerdlow P
      – PersonEntity:
          Name:
            NameFull: Kutlar A
      – PersonEntity:
          Name:
            NameFull: DeCastro L
      – PersonEntity:
          Name:
            NameFull: Waclawiw MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2010 Jun
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-electronic
              Value: 1096-8652
          Numbering:
            – Type: volume
              Value: 85
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: American journal of hematology
              Type: main
ResultId 1